back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-03-14 16:59 Tx date 2023-03-10 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
310,000 | |
| Filed 2022-08-16 18:06 Tx date 2022-08-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-846,125
-21,875 vol $38.68 each |
10,000 | |
| Filed 2022-08-16 18:06 Tx date 2022-08-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,365,853.44
-35,868 vol $38.08 each |
31,875 | |
| Filed 2022-08-16 18:05 Tx date 2022-08-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-7,257 vol |
67,743 | |
| Filed 2022-08-16 18:03 Tx date 2022-08-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+45,000 vol |
75,000 | |
| Filed 2022-08-16 18:03 Tx date 2022-08-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+20,000 vol |
30,000 | |
| Filed 2022-08-16 18:01 Tx date 2022-08-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-213,750
-45,000 vol $4.75 each |
235,000 | |
| Filed 2022-08-16 18:00 Tx date 2022-08-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-62,000
-20,000 vol $3.10 each |
280,000 | |
| Filed 2022-03-14 16:39 Tx date 2022-03-10 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+65,000 vol |
300,000 | |
| Filed 2022-03-08 20:28 Tx date 2022-03-07 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-948,205.92
-31,048 vol $30.54 each |
10,000 | |
| Filed 2022-03-08 20:28 Tx date 2022-03-07 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,269.10
-1,805 vol $30.62 each |
41,048 | |
| Filed 2022-03-08 20:27 Tx date 2022-03-07 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-8,952 vol |
42,853 | |
| Filed 2022-03-08 20:26 Tx date 2022-03-07 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$270,400
+40,000 vol $6.76 each |
51,805 | |
| Filed 2022-03-08 20:25 Tx date 2022-03-07 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-695 vol |
11,805 | |
| Filed 2022-03-08 20:24 Tx date 2022-03-07 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$21,000
+2,500 vol $8.40 each |
12,500 | |
| Filed 2022-03-08 20:23 Tx date 2022-03-04 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-563,918.85
-18,315 vol $30.79 each |
10,000 | |
| Filed 2022-03-08 20:22 Tx date 2022-03-04 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-6,685 vol |
28,315 | |
| Filed 2022-03-08 20:21 Tx date 2022-03-04 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+25,000 vol |
35,000 | |
| Filed 2022-03-08 20:21 Tx date 2022-03-07 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-270,400
-40,000 vol $6.76 each |
235,000 | |
| Filed 2022-03-08 20:20 Tx date 2022-03-07 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-21,000
-2,500 vol $8.40 each |
275,000 | |
| Filed 2022-03-08 20:19 Tx date 2022-03-04 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-210,000
-25,000 vol $8.40 each |
277,500 | |
| Filed 2021-03-15 17:02 Tx date 2021-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+65,000 vol |
302,500 | |
| Filed 2020-03-16 16:43 Tx date 2020-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+65,000 vol |
237,500 | |
| Filed 2019-09-19 15:17 Tx date 2019-09-16 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$377,600
+40,000 vol $9.44 each |
172,500 | |
| Filed 2018-03-13 Tx date 2018-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
132,500 | |
| Filed 2017-10-24 Tx date 2017-10-23 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
87,500 | |
| Filed 2017-08-17 Tx date 2017-08-15 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,824
+10,000 vol $2.48 each |
10,000 | |
| Filed 2017-08-17 Tx date 2016-02-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-14 Tx date 2017-03-13 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+27,500 vol |
67,500 | |
| Filed 2016-02-10 Tx date 2016-02-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
40,000 | |
| Filed 2016-02-10 Tx date 2016-02-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Empfield, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|